Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-02-12

A pancreatic cancer approval; Seres cuts staff

Endpoints News 2026-02-12

Even Europeans don't see a future in Euro biopharma anymore

Endpoints News 2026-02-12

Terray says its AI model beats Boltz-2 at binding affinity prediction

Endpoints News 2026-02-12

Lyell starts first head-to-head CAR-T therapy trial

Endpoints News 2026-02-12

BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins

Endpoints News 2026-02-12

European VCs form coalition to get more support for biotech investing

Endpoints News 2026-02-12

Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO

Endpoints News 2026-02-12

Hinge Health is looking to build AI tools for mental health support

Endpoints News 2026-02-11

FDA may consider Moderna's flu vaccine in a narrower group

Endpoints News 2026-02-11

Former AstraZeneca senior staff charged with illegal trade in China

Endpoints News 2026-02-11

Prasad overruled vaccine review team, office director on Moderna flu shot

Endpoints News 2026-02-11

After CEO departs, CSL details profit crash, $1.1B impairment costs

Endpoints News 2026-02-11

Madrigal pads MASH pipeline with six siRNAs from China's Ribo

Endpoints News 2026-02-11

Gubra forms venture unit; Galecto's $275M offering

Endpoints News 2026-02-11

How a closet full of EKG machines illustrates pharma’s clinical trial cost problem

Endpoints News 2026-02-11

Oscar Health expects explosive growth for 2026, but it comes with a risk

Endpoints News 2026-02-11

Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?

Endpoints News 2026-02-11

Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial

Endpoints News 2026-02-10

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Endpoints News 2026-02-10

Isomorphic claims major advance with new AI drug design engine

-360 / 30